Indian generics sector hires India First Group to re-establish its reputation

USA-based generic drugmakers want high quality, low cost generic pharmaceuticals made in India and the USA, and want the truth to be known across America, as a result of which they have linked with the Washington DC-based India First Group to set the record straight - promoting the benefits of affordable access to medicine as vital.

The advisory firm India First Group (IFG) is tasked to mobilize the Coalition for Affordable Care, “which aims to counter one of the most anti-Indian, negative advocacy campaigns ever witnessed in the two countries' history. “

Forces backed by Big Pharma, including the most powerful special interest business lobby in the USA, Pharmaceutical Research and Manufacturers of America (PhRMA), chaired by Pfizer's chief executive Ian Reid, the Global Intellectual Property Center of the US Chamber of Commerce, and the National Associations of Manufacturers, continue their campaign to downgrade the reputation of Indian pharmaceuticals in order to maintain market share and destroy competition, the action group claims, adding, “Like David against Goliath, the Coalition for Affordable Care - with inner strength and moral authority - will aim to blunt this special interest offensive.”